SCHEMBL5237267

SCHEMBL5237267

CCCC[Sn](CCCC)(CCCC)c1cn2c(-c3ccccc3)nc(C(=O)c3cccnc3)c2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.38
LMNA P02545 4/20 0.38
ALDH1A1 P00352 4/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
CNR2 P34972 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
RAB9A P51151 2/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 3/20 0.34
CYP2C9 P11712 3/20 0.34
TSHR P16473 2/20 0.34
CYP2C19 P33261 2/20 0.34
HTT P42858 2/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5235215 0.90 RAB9A (0.36) S1PR1LMNAALDH1A1KDM4EL3MBTL1
SCHEMBL5234739 0.87 L3MBTL1 (0.38) S1PR1LMNAALDH1A1POLBL3MBTL1
SCHEMBL5235798 0.86 L3MBTL1 (0.37) LMNAALDH1A1POLBL3MBTL1HDAC3
SCHEMBL5234665 0.86 L3MBTL1 (0.37) LMNAALDH1A1POLBL3MBTL1HDAC3
SCHEMBL5238798 0.85 L3MBTL1 (0.36) LMNAALDH1A1POLBL3MBTL1HDAC3
SCHEMBL5237188 0.85 L3MBTL1 (0.36) LMNAALDH1A1POLBL3MBTL1HDAC3
SCHEMBL5231060 0.79 L3MBTL1 (0.39) LMNAALDH1A1POLBL3MBTL1HDAC3
SCHEMBL5235699 0.74 CYP2C9 (0.36) S1PR1LMNAL3MBTL1CNR2CYP1A2
SCHEMBL5238542 0.72 CTSA (0.34) S1PR1CNR2HTTALOX15
SCHEMBL6772586 0.71 ALDH1A1 (0.37) ALDH1A1CNR2RAB9ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1336612-B1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA (JP) 2007-01-17 EP disclosed
US-6908913-B2 Carbapenem derivatives MEIJI SEIKI KAISHA, LTD. (JP) 2005-06-21 US disclosed
US-20040038967-A1 Novel carbapenem derivatives MEIJI SEIKI KAISHA, LTD. (JP) 2004-02-26 US disclosed
EP-1336612-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2003-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038967-A1 Novel carbapenem derivatives DHPS, HAMP, MCRS1 S1PR1 1719/4885LMNA 894/4885ALDH1A1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.